The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) are Illumina reagents, consumables, and related sequencing instruments and services. The contract was awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of genetic sequencing and analysis solutions, without any set-aside provisions.
The contract supports the NIH's requirement for a constant supply of Illumina-branded or equivalent reagents and consumables to operate its extensive fleet of Illumina DNA sequencing systems, including NovaSeq, HiSeq, NextSeq, MiSeq, MiniSeq, iSeq, and iScan models. The scope includes providing reagents capable of high-throughput sequencing up to 6,000 Gb per run, as well as library preparation reagents compatible with a wide range of genomic applications and sample types. The IDC has a total ceiling value of $92,416,478 and a performance period through September 2025. Task orders issued to date, valued at up to $221,897, provide for the delivery of Illumina sequencing systems, reagents, and consumables to various NIH institutes and centers to support their genomic research and diagnostics missions.
Generated 8/31/24, 10:02 AM